Trial Profile
A phase I, Open-label study to evaluate the pharmacokinetics and pharmacodynamics of single and multiple dose of Anacetrapib in Healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2017
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary) ; Anacetrapib (Primary)
- Indications Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Merck & Co
- 12 Apr 2017 New trial record
- 05 Apr 2017 Results published in the Clinical Pharmacology and Therapeutics